MDI-403 is a retinoic acid receptor (RAR) agonist with an EC50 value of less than 1 µM. MDI-403 exhibits significant antiviral activity against SARS-CoV-2, and can dose-dependently inhibit the expression of viral nucleoprotein (NP) and reduce the proportion of infected cells. MDI-403 mainly acts during the virus invasion stage. MDI-403 can be used in research on anti-SARS-CoV-2[1].
Molecular Weight:
448.59
CAS Number:
[127471-94-7]
Formula:
C29H36O4
Target:
RAR/RXR,SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
